Event: ESMO 2022

0:03:35

#ESMO22 Highlights on actionable inflammatory axis for air pollution induced NSCLC

0:00:55

ESMO 2022 highlights

0:01:00

ESMO 2022 Highlights

0:07:00

Expert report on neoadjuvant immune checkpoint inhibitors for NSCLC

0:02:46

#ESMO22 Highlights on neoadjuvant ICI in locally advanced dMMR colon cancer: The NICHE-2 study

0:00:43

Topics and themes of interest at ESMO 2022

0:01:52

ESMO 2022 highlights in head and neck cancer

0:33:28

ESMO 2022: Highlights, commentary and analysis

0:00:32

Highlights in pharmacy at ESMO 2022

0:00:44

Highlights in skin cancer at ESMO 2022

0:03:09

ESMO 2022: Highlights from the Presidential Symposium

0:15:47

Melanoma ESMO 2022 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Sapna Patel

0:06:28

ESMO Expert Report on antibody drug conjugates in the management of urothelial cancer @ASCO GU 2022

0:00:56

Highlights from ESMO WCGIC 2022

0:01:06

Lung cancer highlights from ESMO 2022

0:01:28

Highlights from ESMO 2022 in melanoma

0:01:45

Clincal trial highlights in breast cancer at ESMO 2022

0:02:51

Breast cancer trials of interest at ESMO 2022

0:00:55

Upcoming updates in GU cancers at ESMO 2022

0:01:16

ESMO Asia 2023: Sanjay Popat on the programme of this influential Asia-Pacific oncology event

0:01:09

Key trials in GU cancers from ESMO 2022

0:07:28

Expert Report on panitumumab for first line treatment of RAS wild type mCRC from ASCO 2022

0:01:54

Highlights in lung cancer at ESMO 2022

0:00:30

What to look forward to in GU at ESMO 2022?